Schedule 13G ownership disclosure
Arch Therapeutics, Inc.
Security class unavailable · CUSIP: 03939W109
Event date: 2016-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 9,911,667
- Percent of class
- 7.1900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001185185-17-000226
- Form type
- SC 13G
- Filer
- Arch Therapeutics, Inc.
- CIK
- CIK 1537561
- Filed
- Feb 09, 2017
- Reporting period
- Dec 31, 2016
- Description
- Schedule 13G beneficial ownership